← Leaderboards
Steve Hauschild
Sigmovir Biosystems, Inc.
$3,233,329
Attributed
$3,233,329
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $984.6K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,233,329 · 1
By mechanism
N01$3,233,329 · 1
Top collaborators
No co-investigators on record.
Most similar at Sigmovir Biosystems, Inc.
Same institution · by research overlap
- Marina Boukhvalova$1,044,710
Others in their field
Other Emerging Leaders on “Vaccine Evaluation”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Yunda Huang · Fred Hutchinson Cancer Center$74,632,633
- Ted Ross · University Of Georgia$71,962,304
- Tony Moody · Duke University$68,608,541
- Theresa Engel · Leidos Biomedical Research, Inc.$63,678,091
- Matthew Johnson · Duke University$61,899,930
Research focus
Vaccine EvaluationInfectious Disease ModelContractsCotton RatsVirusAnimal ModelEfficacy TestingLicensureRespiratory Syncytial VirusStandardizationVaccinesParamyxovirusParamyxovirus VaccineAnimal Model DevelopmentTherapeutic DevelopmentEvaluationRespiratory VirusVaccine Development
Grant awards (5)
Task A88: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses$282,719
N01 · FY2025 · AI · contact PI
Task A88: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses$407,153
N01 · FY2024 · AI · contact PI
Task A88: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses$836,688
N01 · FY2023 · AI · contact PI
Task A45: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses$722,205
N01 · FY2022 · AI · contact PI
Task A45: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related Viruses$984,564
N01 · FY2020 · AI · contact PI